新冠疫情期间心肺疾病患者的药物治疗调整 - Suppr

Suppr

超能文献

Pharmacotherapeutic Modifications in Cardiopulmonary Patients during COVID-19 Outbreak.

作者信息

Khan Imran Ahmad

机构信息

Department of Rehabilitation Sciences, Muhammad Institute of Medical & Allied Sciences, Multan, Pakistan.

出版信息

J Coll Physicians Surg Pak. 2020 Oct;30(10):132-133. doi: 10.29271/jcpsp.2020.supp2.132.

DOI:10.29271/jcpsp.2020.supp2.132

PMID:33115588

Abstract

摘要

相似文献

Pharmacotherapeutic Modifications in Cardiopulmonary Patients during COVID-19 Outbreak.

J Coll Physicians Surg Pak. 2020 Oct;30(10):132-133. doi: 10.29271/jcpsp.2020.supp2.132.

Managing Your Chronic Lung Disease during the COVID-19 Pandemic.

Am J Respir Crit Care Med. 2020 Jul 15;202(2):P5-P6. doi: 10.1164/rccm.2020C8.

Utilization and Appropriateness of Transthoracic Echocardiography in Response to the COVID-19 Pandemic.

J Am Soc Echocardiogr. 2020 Jun;33(6):690-691. doi: 10.1016/j.echo.2020.04.006. Epub 2020 Apr 10.

Has Venoarterial ECMO Been Underutilized in COVID-19 Patients?

Innovations (Phila). 2020 Jul/Aug;15(4):317-321. doi: 10.1177/1556984520939076. Epub 2020 Jul 7.

On being a neurologist in Italy at the time of the COVID-19 outbreak.

Neurology. 2020 May 26;94(21):905-906. doi: 10.1212/WNL.0000000000009508. Epub 2020 Apr 3.

CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic.

Eur Heart J. 2020 May 14;41(19):1795-1796. doi: 10.1093/eurheartj/ehaa280.

An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.

JAMA Cardiol. 2020 Jul 1;5(7):743-744. doi: 10.1001/jamacardio.2020.0934.

[Expert consensus on principal of clinical management of patients with severe emergent cardiovascular diseases during the epidemic period of COVID-19].

Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 24;48(3):189-194. doi: 10.3760/cma.j.cn112148-20200210-00066.

Fear of Coronavirus Disease 2019-An Emerging Cardiac Risk.

JAMA Cardiol. 2020 Sep 1;5(9):981-982. doi: 10.1001/jamacardio.2020.2890.

SCAI initiatives during the COVID-19 pandemic.

Catheter Cardiovasc Interv. 2020 Nov;96(5):995-996. doi: 10.1002/ccd.29058. Epub 2020 Jun 20.

引用本文的文献

Cardioprotective Effect of Linn. Leaf Extract against Catecholamine-Induced Cardiotoxicity.

Molecules. 2022 May 24;27(11):3383. doi: 10.3390/molecules27113383.

Pharmacological Justification for the Medicinal Use of Linn. in Cardiovascular Disorders.

Molecules. 2021 Dec 31;27(1):251. doi: 10.3390/molecules27010251.

: A Potential Candidate for Drug Development to Cure Cardiovascular Ailments.

Molecules. 2021 Sep 18;26(18):5664. doi: 10.3390/molecules26185664.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Pharmacotherapeutic Modifications in Cardiopulmonary Patients during COVID-19 Outbreak.

J Coll Physicians Surg Pak. 2020 Oct;30(10):132-133. doi: 10.29271/jcpsp.2020.supp2.132.

Managing Your Chronic Lung Disease during the COVID-19 Pandemic.

Am J Respir Crit Care Med. 2020 Jul 15;202(2):P5-P6. doi: 10.1164/rccm.2020C8.

Utilization and Appropriateness of Transthoracic Echocardiography in Response to the COVID-19 Pandemic.

J Am Soc Echocardiogr. 2020 Jun;33(6):690-691. doi: 10.1016/j.echo.2020.04.006. Epub 2020 Apr 10.

Has Venoarterial ECMO Been Underutilized in COVID-19 Patients?

Innovations (Phila). 2020 Jul/Aug;15(4):317-321. doi: 10.1177/1556984520939076. Epub 2020 Jul 7.

On being a neurologist in Italy at the time of the COVID-19 outbreak.

Neurology. 2020 May 26;94(21):905-906. doi: 10.1212/WNL.0000000000009508. Epub 2020 Apr 3.

CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic.

Eur Heart J. 2020 May 14;41(19):1795-1796. doi: 10.1093/eurheartj/ehaa280.

An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.

JAMA Cardiol. 2020 Jul 1;5(7):743-744. doi: 10.1001/jamacardio.2020.0934.

[Expert consensus on principal of clinical management of patients with severe emergent cardiovascular diseases during the epidemic period of COVID-19].

Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 24;48(3):189-194. doi: 10.3760/cma.j.cn112148-20200210-00066.

Fear of Coronavirus Disease 2019-An Emerging Cardiac Risk.

JAMA Cardiol. 2020 Sep 1;5(9):981-982. doi: 10.1001/jamacardio.2020.2890.

SCAI initiatives during the COVID-19 pandemic.

Catheter Cardiovasc Interv. 2020 Nov;96(5):995-996. doi: 10.1002/ccd.29058. Epub 2020 Jun 20.

引用本文的文献

Cardioprotective Effect of Linn. Leaf Extract against Catecholamine-Induced Cardiotoxicity.

Molecules. 2022 May 24;27(11):3383. doi: 10.3390/molecules27113383.

Pharmacological Justification for the Medicinal Use of Linn. in Cardiovascular Disorders.

Molecules. 2021 Dec 31;27(1):251. doi: 10.3390/molecules27010251.

: A Potential Candidate for Drug Development to Cure Cardiovascular Ailments.

Molecules. 2021 Sep 18;26(18):5664. doi: 10.3390/molecules26185664.